Volition Sponsors Symposium at Veterinary Meeting and Expo
VolitionRX Limited (VNRX)
NASDAQ:AMEX Investor Relations:
ir.volitionrx.com
Company Research
Source: PR Newswire
HENDERSON, Nev., Jan. 16, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the sponsorship of an industry symposium at the world's leading veterinary education conference, Veterinary Meeting and Expo ("VMX") in Orlando, Florida.Dr. Sue Ettinger, DVM, DACVIM (Oncology) aka "Dr Sue Cancer Vet" will present"Utilizing the Nu.Q® Vet Cancer Test in Practice" on Monday, January 19 at 2.45pm EST.Dr. Tom Butera, Chief Executive Officer, Volition Veterinary Diagnostics Development LLC commented:"We are excited to attend VMX 2026 and are delighted that Dr Sue Ettinger will be sharing her extensive experience with our Nu.Q® Vet Cancer Test.By incorporating the Nu.Q® Canine Cancer Test into annual checkups or regular senior wellness exams, veterinarians can detect cancer earlier¹ and help pet owners make timely, informed decisions about cancer care.This is our busiest conference with approximately 20,000 veterinary profess
Show less
Read more
Impact Snapshot
Event Time:
VNRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VNRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VNRX alerts
High impacting VolitionRX Limited news events
Weekly update
A roundup of the hottest topics
VNRX
News
- VolitionRx (NYSE:VNRX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $3.00 price target on the stock.MarketBeat
- VolitionRx Announces Breakthrough Clinical Data for Nu.Q® Vet Cancer Test in Cats [Yahoo! Finance]Yahoo! Finance
- VolitionRx Secures $2.0 Million in FundingPR Newswire
- VolitionRx Announces Breakthrough Clinical Data for Nu.Q® Vet Cancer Test in CatsPR Newswire
- VolitionRx (NYSE:VNRX) had its price target lowered by analysts at D. Boral Capital from $5.00 to $3.00. They now have a "buy" rating on the stock.MarketBeat
VNRX
Earnings
- 11/13/25 - Miss
VNRX
Sec Filings
- 1/8/26 - Form 8-K
- 12/11/25 - Form 8-K
- 11/17/25 - Form 4
- VNRX's page on the SEC website